Verve Ventures

Founded in 2010, Verve Ventures is a European venture capital firm headquartered in Switzerland. It operates a digital investment platform for qualified investors, enabling them to build diversified startup portfolios with investments starting at EUR 10,000. With over EUR 130 million invested in over 100 startups and a community of 5,000 registered investors, Verve Ventures focuses on science and technology sectors, sourcing top deals and structuring rounds for its investors.

Bernardo Delarue Bizzini

Associate

Michael Blank

Investor

Romeo Bütler

Investor

Oleg Chervonnyi

Analyst

Cindi Choi

Managing Director

Joāo Duarte

Investor

Chris Gay-Crosier

Investor

Samir Jola

Analyst

Patrick Kroneman

Venture Capitalist

Martin Lehmann

Senior Investment Associate

Michael Lütolf

Investor

Thomas Meier

Associate

Xavier Mesnier

Investor

Julien Pache

Venture Partner

Emma Schepers

Associate

Susanne Schorsch

Investor

Alexander Seel

Investor

Paulina Vachet

Associate

Lukas Weber

Co-Founder, CEO and Board Member

Thibault De Keersmaecker

Investor

Past deals in Switzerland

Axelera AI

Series B in 2024
Axelera AI specializes in developing hardware and software platforms designed to accelerate artificial intelligence tasks, particularly for edge computing. Its flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions. The company is headquartered in Eindhoven with R&D offices in Belgium, Switzerland, and Italy.

Bcomp

Series C in 2024
Bcomp Ltd., founded in 2003 and headquartered in Fribourg, Switzerland, specializes in manufacturing natural fiber composites. The company's primary products include ampliTex (natural flax fiber), bCores (lightweight wood core), and powerRibs (natural fiber composite reinforcement). Bcomp serves industries such as sports, automotive, acoustics, aerospace, electronics, design, and leisure by providing eco-friendly alternatives to traditional materials.

Artiria Medical

Series A in 2024
Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.

Transmutex

Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

Memo Therapeutics

Series C in 2023
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Nagi Bioscience

Series A in 2023
Nagi Bioscience develops automated testing devices that use Caenorhabditis elegans worms to screen molecules for pharmaceutical, chemical and cosmetic applications. Its Organism-on-Chip platform combines whole-organism biology with an automated in vitro workflow for culture, treatment, and multi-parametric analysis, enabling toxicity testing, drug discovery, and anthelmintic screening. The technology links in vivo worm models with a fully automated platform to observe biological responses that emerge at the whole-organism level. The company is headquartered in Lausanne, Switzerland.

Hylomorph

Series B in 2023
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Verity Studios

Series B in 2023
Verity Studios designs and supplies autonomous indoor drone systems and provides end-to-end drone show production for live events, theatre, and entertainment. Founded in 2014 and based in Zurich, Switzerland, the company develops synthetic swarm and stage drones and delivers global drone shows for venues and tours, with clients including Cirque du Soleil and major arenas. Its autonomous drone technology is also used in warehouse environments for inventory tracking to improve operational efficiency, reduce labor and equipment costs, and lower waste and emissions. Verity operates worldwide, offering turnkey production services and customized drone solutions for both live events and industrial applications.

Axelera AI

Series A in 2023
Axelera AI specializes in developing hardware and software platforms designed to accelerate artificial intelligence tasks, particularly for edge computing. Its flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions. The company is headquartered in Eindhoven with R&D offices in Belgium, Switzerland, and Italy.

ANYbotics

Series B in 2023
Founded in 2016, ANYbotics develops autonomous legged robots designed for industrial applications. These robots are equipped with features such as docking stations, robust sensing capabilities, and waterproofing. They also offer tools for reading instruments, monitoring equipment health, detecting events, and inspecting complex environments. The company aims to improve worker safety, increase productivity, and support sustainable operations in industries like oil and gas, power, mining, chemicals, construction, and transportation.

ecoRobotix

Series B in 2023
ecoRobotix is a Swiss developer of autonomous weeding machines for row crops, meadows, and intercropping cultures. The company builds systems that use vision, cameras, GPS RTK, and sensors to follow crop rows, identify weeds, and guide robotic arms to apply micro-doses of herbicide directly to target weeds, enabling precision spraying and reducing chemical use. Its solutions aim to lower environmental impact and farming costs by enabling ecological and economical weed control. Founded in 2011 and based in Yverdon-les-Bains, Switzerland, ecoRobotix markets platforms that cover inter-row spaces as well as crop rows, delivering substantial reductions in chemical applications while maintaining yields.

Wingtra

Series B in 2023
Wingtra is a Swiss drone manufacturer that designs the WingtraOne, a vertical take-off and landing VTOL fixed-wing drone that combines plane-like efficiency with VTOL versatility to deliver high-precision aerial data for surveying, mapping, and infrastructure projects. The platform supports sectors including construction, mining, agriculture, forestry, environmental monitoring, urban planning, and land management by capturing detailed data over large areas. Founded in 2014 and launching its market-ready product in 2017, Wingtra serves a global customer base through a network of surveying equipment dealers, enabling professionals to digitize and monitor surroundings with reliable flight performance.

Flyability

Series C in 2023
Flyability develops and manufactures flying drones for inspection and exploration of indoor, inaccessible, and confined spaces. Its flagship drone, Elios, is collision-tolerant and enables industrial inspectors to access complex indoor environments safely. The company provides flying kits, spare parts, training, and after-sales support. Founded in 2014 and headquartered in Lausanne, Switzerland, Flyability focuses on industrial inspection to reduce risk by enabling drone operation inside cities, buildings, and near people, supporting inspections of critical infrastructures such as power generation, oil and gas, and maritime facilities, as well as search and rescue and security applications.

Flyability

Series C in 2022
Flyability develops and manufactures flying drones for inspection and exploration of indoor, inaccessible, and confined spaces. Its flagship drone, Elios, is collision-tolerant and enables industrial inspectors to access complex indoor environments safely. The company provides flying kits, spare parts, training, and after-sales support. Founded in 2014 and headquartered in Lausanne, Switzerland, Flyability focuses on industrial inspection to reduce risk by enabling drone operation inside cities, buildings, and near people, supporting inspections of critical infrastructures such as power generation, oil and gas, and maritime facilities, as well as search and rescue and security applications.

Invasight

Seed Round in 2022
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

holo|one

Series A in 2022
holo|one is a software company developing “sphere” – the award-winning, standardized Mixed Reality (MR) platform solution. It hails from Switzerland, with offices in Zurich, the Bay Area, and Chongqing, China.

Sleepiz

Series A in 2022
Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.

9T Labs

Series A in 2022
Founded in 2018, 9T Labs specializes in manufacturing advanced 3D printers that produce carbon composites. Their proprietary technology combines software, additive manufacturing, and industry-standard materials to deliver digital composite production solutions. This enables manufacturers to create lighter structural parts with true 3D fiber orientation at a lower cost.

Memo Therapeutics

Series B in 2022
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Nanoleq

Series A in 2021
Nanoleq develops and manufactures electric cables using stretchable electronics, serving sectors such as healthcare, robotics, aerospace, and electronics. Its products include shields and conductors for various applications.

Hylomorph

Series B in 2021
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Seervision

Funding Round in 2021
Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.

Scewo

Series A in 2021
Founded in 2017, Scewo designs and manufactures innovative electric wheelchairs for individuals with mobility impairments. Its flagship product is a stair-climbing wheelchair that combines wheels and tracks with an active control system, enabling users to navigate various terrains and obstacles.

Sleepiz

Series A in 2021
Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.

ecoRobotix

Venture Round in 2021
ecoRobotix is a Swiss developer of autonomous weeding machines for row crops, meadows, and intercropping cultures. The company builds systems that use vision, cameras, GPS RTK, and sensors to follow crop rows, identify weeds, and guide robotic arms to apply micro-doses of herbicide directly to target weeds, enabling precision spraying and reducing chemical use. Its solutions aim to lower environmental impact and farming costs by enabling ecological and economical weed control. Founded in 2011 and based in Yverdon-les-Bains, Switzerland, ecoRobotix markets platforms that cover inter-row spaces as well as crop rows, delivering substantial reductions in chemical applications while maintaining yields.

Qnami

Series A in 2021
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

RAW Labs

Seed Round in 2021
RAW Labs is a Lausanne, Switzerland-based company founded in 2015 that enables organizations to build and deploy data-driven applications and data-as-a-service. It develops NoDB, a data management approach that handles growing, diverse, and dispersed data without creating data lakes or warehouses, and RQL, a query engine for exposing raw and operational data. The company offers products including RAW Starter, RAW Professional, and RAW Enterprise. In addition, it provides an enterprise AI governance platform that combines secure infrastructure with real-time policy enforcement to monitor access by AI agents, deliver structured, validated responses, and support setup and authentication, helping developers prevent issues before they occur. RAW Labs aims to tame big data growth by federating and querying raw data in-situ.

NetGuardians

Series D in 2020
NetGuardians develops fraud prevention and risk management software that analyzes user behavior and transactional data to detect atypical activity, prevent fraud, and automate compliance. Its FraudGuardian product targets banking fraud across channels, providing predefined controls and continuous auditing of activities in mobile and online banking, payments, and identity protection. RiskGuardian offers regulatory templates, automated controls, and visualization and reporting to support ongoing compliance. The platform relies on big data and smart behavioral analytics and can be configured for other sectors beyond banking. NetGuardians serves midsized banks and financial institutions worldwide through reseller channels and is headquartered in Yverdon-les-Bains, Switzerland.

Guuru

Series A in 2020
Guuru Ltd. is a cloud software company based in Zurich, Switzerland, founded in 2015. It operates an expertise-sharing platform that connects clients with experts across various fields through live chat. The platform allows users to post questions and receive real-time, one-on-one responses from knowledgeable individuals, facilitating a more efficient and informed decision-making process for potential customers. By integrating community-driven insights into online shopping experiences, Guuru fosters authentic connections between brands and their audiences, enhancing customer engagement and satisfaction. The company's international team is skilled in supporting diverse markets, providing services in multiple languages to meet the needs of a global clientele.

Verity Studios

Convertible Note in 2020
Verity Studios designs and supplies autonomous indoor drone systems and provides end-to-end drone show production for live events, theatre, and entertainment. Founded in 2014 and based in Zurich, Switzerland, the company develops synthetic swarm and stage drones and delivers global drone shows for venues and tours, with clients including Cirque du Soleil and major arenas. Its autonomous drone technology is also used in warehouse environments for inventory tracking to improve operational efficiency, reduce labor and equipment costs, and lower waste and emissions. Verity operates worldwide, offering turnkey production services and customized drone solutions for both live events and industrial applications.

Memo Therapeutics

Series B in 2020
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Artiria Medical

Series A in 2020
Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.

Metaco

Series A in 2020
Metaco is a Swiss company that specializes in providing digital asset management solutions for financial institutions. It offers a comprehensive orchestration platform that allows institutions to issue, secure, manage, and trade a diverse range of digital assets, including cryptocurrencies, tokens, and smart contracts. The company’s platform supports the entire lifecycle of asset tokens with a robust smart contract framework, facilitating the management of various asset classes such as equities, bonds, and derivatives. Metaco's technology ensures a secure and agile digital asset vault for self-custody, while also providing connectivity to over 50 exchanges, brokers, and market makers, thus enabling seamless trading and efficient risk management for its clients.

Mobbot

Seed Round in 2020
Mobbot SA is a Swiss company based in Fribourg, established in 2018, that specializes in 3D concrete printing technology for the construction industry. The company focuses on providing digital fabrication systems that allow construction firms to produce custom-made concrete products efficiently. By integrating passive reinforcement and utilizing conventional concrete from ready-mix plants, Mobbot's technology significantly reduces both production and installation costs. It streamlines construction processes, enabling projects that would typically require three days of work on-site to be completed in just one hour. This innovation aims to enhance productivity and cost-effectiveness for infrastructure projects.

Pregnolia

Series A in 2020
Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.

Archilyse

Series A in 2020
Archilyse AG is a Zurich-based software company founded in 2017 that specializes in numeric architectural analysis. The firm offers a Software-as-a-Service solution that enables real estate professionals, including portfolio managers and developers, to analyze and optimize various processes throughout the real estate lifecycle. Archilyse's software converts 2D floor plans into 3D models and utilizes a range of simulations—such as view, geometrical, connectivity, and physical analysis—to derive valuable insights about architectural quality. The application allows users to visualize data through heatmaps and export key performance metrics for further analysis. By addressing the information imbalance in the real estate sector, Archilyse enhances the decision-making capabilities of its clients, promoting a more data-driven approach to property evaluation and portfolio management.

9T Labs

Seed Round in 2020
Founded in 2018, 9T Labs specializes in manufacturing advanced 3D printers that produce carbon composites. Their proprietary technology combines software, additive manufacturing, and industry-standard materials to deliver digital composite production solutions. This enables manufacturers to create lighter structural parts with true 3D fiber orientation at a lower cost.

Wyden

Series A in 2020
Wyden is a global leader in institutional digital asset trading technology. Its platform covers the entire trade lifecycle—from pre‑trade risk checks and order generation to automated settlement—while integrating custody, core banking, and portfolio management systems. Built by a team of trading system veterans and crypto asset experts, the solution delivers full trade‑lifecycle automation and seamless integration with traditional financial infrastructure, enabling institutions to bridge digital and conventional assets.

Nagi Bioscience

Seed Round in 2019
Nagi Bioscience develops automated testing devices that use Caenorhabditis elegans worms to screen molecules for pharmaceutical, chemical and cosmetic applications. Its Organism-on-Chip platform combines whole-organism biology with an automated in vitro workflow for culture, treatment, and multi-parametric analysis, enabling toxicity testing, drug discovery, and anthelmintic screening. The technology links in vivo worm models with a fully automated platform to observe biological responses that emerge at the whole-organism level. The company is headquartered in Lausanne, Switzerland.

Qnami

Seed Round in 2019
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

Picstars

Venture Round in 2019
Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

Yonder AG

Seed Round in 2019
Yonder AG is a Swiss company based in Zurich, founded in 2015, that specializes in documentation-as-a-service (DaaS) solutions. The company's flagship offering, Yonder Mind, is an application designed for efficient information management, enabling organizations to create, maintain, and deliver information effectively to users. Yonder AG focuses on streamlining the documentation process by providing shorter, more relevant documents and manageable revisions, alongside services for document content creation and conversion. Through its innovative solutions, Yonder AG aims to enhance the way businesses handle their information needs.

Versantis

Series B in 2019
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.

Haelixa

Seed Round in 2019
Haelixa LLC, founded in 2012 and based in Zürich, Switzerland, specializes in DNA-based tracing and tagging technology aimed at enhancing supply chain transparency and integrity. The company develops innovative tracing solutions for various sectors, including the energy industry, where it offers water and oil tracers to monitor the movement of fluids in subsurface environments, as well as groundwater tracing solutions. Beyond the energy sector, Haelixa provides product identification solutions that help prevent counterfeiting and other irregularities, thereby reinforcing supply chain sustainability. Its proprietary platform enables clients to physically mark, trace, and authenticate products from production to retail, ensuring brand protection and proof of authenticity for a wide range of goods, including textiles and precious materials.

Seervision

Seed Round in 2019
Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.

ActLight

Series C in 2019
ActLight SA, based in Lausanne, Switzerland, is a technology company specializing in the development of advanced photodetectors and photovoltaic energy harvesting solutions. Founded in 2010, ActLight has pioneered Dynamic PhotoDiode (DPD) technology, significantly enhancing the efficiency and accuracy of light sensing applications across various sectors, including mobile devices, healthcare, autonomous driving, and robotics. The company's innovations enable functionalities such as heart rate monitoring, gesture control, and 3D imaging. ActLight operates primarily on a licensing business model, generating revenue through licensing and royalty fees, as well as non-recurring engineering projects. As a fabless entity, it focuses on intellectual property in CMOS photonics and collaborates with leading institutions like EPFL to maintain its competitive edge. ActLight's expertise encompasses device design, materials integration, and circuit design, supported by a strong advisory board of industrial and scientific experts.

Wingtra

Series A in 2019
Wingtra is a Swiss drone manufacturer that designs the WingtraOne, a vertical take-off and landing VTOL fixed-wing drone that combines plane-like efficiency with VTOL versatility to deliver high-precision aerial data for surveying, mapping, and infrastructure projects. The platform supports sectors including construction, mining, agriculture, forestry, environmental monitoring, urban planning, and land management by capturing detailed data over large areas. Founded in 2014 and launching its market-ready product in 2017, Wingtra serves a global customer base through a network of surveying equipment dealers, enabling professionals to digitize and monitor surroundings with reliable flight performance.

Piavita

Series A in 2019
Piavita AG, founded in 2016 and headquartered in Zurich, Switzerland, specializes in developing advanced technology for the veterinary industry. The company has created a compact, matchbox-sized wearable device that accurately measures vital medical data from pets, including horses, without the need for clipping fur or extensive preparation. This innovative system is complemented by a web-based application that enables real-time monitoring and historical tracking of vital signs, improving the diagnostic capabilities available to veterinarians. By providing reliable insights into pet health and facilitating better communication between pet owners and veterinary professionals, Piavita aims to lead the digital transformation of veterinary care, addressing the gaps in current veterinary practices and enhancing the overall wellbeing of animals.

Guuru

Series A in 2019
Guuru Ltd. is a cloud software company based in Zurich, Switzerland, founded in 2015. It operates an expertise-sharing platform that connects clients with experts across various fields through live chat. The platform allows users to post questions and receive real-time, one-on-one responses from knowledgeable individuals, facilitating a more efficient and informed decision-making process for potential customers. By integrating community-driven insights into online shopping experiences, Guuru fosters authentic connections between brands and their audiences, enhancing customer engagement and satisfaction. The company's international team is skilled in supporting diverse markets, providing services in multiple languages to meet the needs of a global clientele.

Wildbiene + Partner

Series B in 2019
Wildbiene + Partner designs and produces bee homes that provide safe nesting sites for mason bees on balconies and in gardens. By encouraging the presence of these pollinators, the company enhances pollination of wild plants and fruit trees, benefiting local ecosystems and agriculture. Its activities include targeted propagation of wild bees, creation of habitats, and educational outreach to raise awareness about the importance of pollinators in Switzerland. The company’s holistic approach aims to sustain bee populations and improve pollination services for both natural and cultivated landscapes.

InterAx Biotech

Series A in 2019
InterAx Biotech Ltd is a biotechnology company based in Villigen, Switzerland, focused on developing a platform for the discovery of functionally selective drugs targeting G-Protein Coupled Receptors (GPCRs). Founded in 2016, the company integrates bioanalytical methods and computational pharmacology to assist in drug candidate design and selection. Its innovative platform combines high-throughput biochemical screening with artificial intelligence and mathematical modeling of cell signaling, facilitating the identification and optimization of drug candidates for various diseases, including those associated with orphan GPCRs. Through its advanced approach, InterAx Biotech aims to improve drug efficacy while reducing side effects, contributing to the healthcare industry's efforts to discover safer and more effective treatments.

Seervision

Seed Round in 2018
Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.

Luciole Medical

Series A in 2018
Luciole Medical AG is a Swiss medical technology company that specializes in the design and manufacture of brain oxygenation monitoring systems. Founded in 2017 and based in Zurich, the company has developed a platform that accurately measures the levels of oxygenated and deoxygenated hemoglobin, as well as cerebral blood flow and other critical parameters. Its product lineup includes RheoPatch, a non-invasive sensor applied to the skin to assess oxygen metabolism and blood flow; RheoSens, an implantable probe that measures various cerebral metrics; RheoLity, which offers software for data display, analysis, and patient management; and RheoControl, which connects to medical monitors for data visualization. Luciole Medical's systems enable healthcare professionals to monitor cerebral oxygenation effectively, providing crucial insights into the patient's brain health.

Hylomorph

Series A in 2018
Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

TestingTime

Series A in 2018
TestingTime AG is a Swiss company founded in 2014 and based in Zurich, specializing in online test user recruitment for usability studies, focus groups, interviews, and surveys. The company serves the UX and market research sectors by providing access to a diverse pool of over 350,000 test users, facilitating the selection of participants tailored to specific research needs. TestingTime employs online campaigns and referral strategies to acquire test users, while utilizing a smart rating system and predictive machine learning algorithms to ensure high-quality participants with a low no-show rate. Its services are offered in multiple languages, including German, French, Italian, Romansh, and English. TestingTime's platform enables large corporations, such as UBS, Zalando, Microsoft, and Accenture, to conduct qualitative and quantitative user research efficiently, enhancing their ability to gather valuable insights.

ecoRobotix

Series A in 2018
ecoRobotix is a Swiss developer of autonomous weeding machines for row crops, meadows, and intercropping cultures. The company builds systems that use vision, cameras, GPS RTK, and sensors to follow crop rows, identify weeds, and guide robotic arms to apply micro-doses of herbicide directly to target weeds, enabling precision spraying and reducing chemical use. Its solutions aim to lower environmental impact and farming costs by enabling ecological and economical weed control. Founded in 2011 and based in Yverdon-les-Bains, Switzerland, ecoRobotix markets platforms that cover inter-row spaces as well as crop rows, delivering substantial reductions in chemical applications while maintaining yields.

GotCourts

Seed Round in 2018
GotCourts Ltd is a software as a service (SaaS) platform based in Zurich, Switzerland, that specializes in the online community for racquet sports enthusiasts. Established in 2014, GotCourts provides tools for players, coaches, and court operators, facilitating the booking of courts and coaching services. The platform allows users to find playing partners, track their progress, and stay connected with fellow racquet sport participants. By aiming to become a comprehensive hub for tennis and other racquet sports, GotCourts enhances the experience for sports lovers, streamlining processes and unlocking the potential of the racquet sports community.

Memo Therapeutics

Series A in 2018
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

arviem

Series B in 2018
arviem provides global cargo monitoring and supply chain visibility services, offering fully managed in-transit tracking and security monitoring across land, sea, and air. The company combines sensing, analytics, and operations support with advisory services such as business consulting and system integration to help clients optimize supply chains. Its platform delivers real-time data on shipment location and condition, enabling data-driven decisions related to logistics, risk management, and working capital. Serving industries including consumer products, consumer electronics, pharma and biochemical, chemical, logistics, and insurance, arviem operates across Europe, Asia, and the Americas. It offers 24/7 global monitoring through a managed service model and provides independent data to support trust and transparency. Strategic partnerships in technology and logistics enhance capabilities in tracking, security, and compliance. Headquartered in Rotkreuz, Switzerland, arviem supports importers, exporters, and logistics providers seeking end-to-end visibility of cargo movements.

Abionic

Series C in 2018
Abionic develops innovative nanotechnology-based diagnostic solutions. Its flagship product, abioSCOPE, enables rapid allergy profiling from a single drop of blood, improving medical diagnosis at clinical labs and point-of-care settings.

Pregnolia

Seed Round in 2018
Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.

Medyria

Series B in 2018
Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.

Picstars

Series A in 2018
Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

KiWi

Seed Round in 2018
KiWi operates a mobile point-of-sale platform that enables micro, small, and medium enterprises to accept credit and debit card payments via smartphones and tablets. The service is designed to be user-friendly and offers the lowest commission rates in the market, eliminating forced deadlines, monthly payments, or annuities. By promoting the acceptance of card payments, KiWi aims to enhance financial security and accuracy for its users, ultimately supporting business growth and improving cash flow for entrepreneurs.

CleanGreens Solutions SA

Series A in 2017
CleanGreens Solutions SA is an agricultural technology company based in Molondin, Switzerland, focused on innovative methods for growing fresh lettuce. Established in 2012, the company utilizes mobile aeroponics, which significantly reduces water consumption and minimizes contamination risks. By integrating advancements in logistics, agronomy, climate control, and automation, CleanGreens Solutions aims to achieve up to 70 times the productivity compared to traditional farming methods. This approach not only enhances the quality and longevity of the lettuce but also ensures that customers receive fresh and pesticide-free produce. Through its commitment to sustainability and efficiency, CleanGreens Solutions is transforming the supply chain for fresh greens.

ActLight

Series B in 2017
ActLight SA, based in Lausanne, Switzerland, is a technology company specializing in the development of advanced photodetectors and photovoltaic energy harvesting solutions. Founded in 2010, ActLight has pioneered Dynamic PhotoDiode (DPD) technology, significantly enhancing the efficiency and accuracy of light sensing applications across various sectors, including mobile devices, healthcare, autonomous driving, and robotics. The company's innovations enable functionalities such as heart rate monitoring, gesture control, and 3D imaging. ActLight operates primarily on a licensing business model, generating revenue through licensing and royalty fees, as well as non-recurring engineering projects. As a fabless entity, it focuses on intellectual property in CMOS photonics and collaborates with leading institutions like EPFL to maintain its competitive edge. ActLight's expertise encompasses device design, materials integration, and circuit design, supported by a strong advisory board of industrial and scientific experts.

DBS System

Series A in 2017
DBS System SA is a medtech company based in the Swiss Health Valley that specializes in the production of HemaXis™ blood collection devices. The company utilizes advanced microfluidic technology to create innovative devices designed for the less invasive, safer, and more efficient collection and preparation of blood samples. HemaXis devices facilitate plasma and serum extraction with precision and in a standardized format, significantly enhancing the capabilities of dried blood spot samples in bioanalysis. By streamlining blood collection processes, DBS System aims to support health monitoring and testing while contributing to the advancement of personalized medicine and big data initiatives.

ecoRobotix

Seed Round in 2016
ecoRobotix is a Swiss developer of autonomous weeding machines for row crops, meadows, and intercropping cultures. The company builds systems that use vision, cameras, GPS RTK, and sensors to follow crop rows, identify weeds, and guide robotic arms to apply micro-doses of herbicide directly to target weeds, enabling precision spraying and reducing chemical use. Its solutions aim to lower environmental impact and farming costs by enabling ecological and economical weed control. Founded in 2011 and based in Yverdon-les-Bains, Switzerland, ecoRobotix markets platforms that cover inter-row spaces as well as crop rows, delivering substantial reductions in chemical applications while maintaining yields.

Lunchgate

Venture Round in 2016
Lunchgate AG, established in 2009 and based in Zurich, Switzerland, operates an online platform that facilitates restaurant discovery and table reservations. The platform offers users daily lunch menus, restaurant specialties, and 360-degree interior views, enabling them to explore and book tables at various dining establishments in the Zurich area.

DomoHealth

Series A in 2016
DomoHealth is a company that specializes in smart home care services aimed at enhancing the quality of life for seniors and their families. Founded in 2011 by Edouard Goupy and Guillaume DuPasquier, the company emerged from personal experiences that highlighted the need for better care solutions. Between 2012 and 2014, DomoHealth conducted extensive trials and feasibility studies across various European countries, receiving validations from care networks, hospitals, and families. Since 2015, the company has marketed its services through a partner network in Europe, emphasizing a collaborative approach that involves listening to the needs of seniors, families, doctors, and nurses. DomoHealth has demonstrated the effectiveness of its services through partnerships with care networks and has been recognized as an expert in homecare within the framework of the European Commission's AAL program.

Planet Intus

Series A in 2016
Planet Intus SA is a Swiss company specializing in the design and development of indoor geolocation software. Founded in 2014 and headquartered in Carouge, Switzerland, the company leverages a combination of French telecommunications expertise and Swiss quality standards. Planet Intus provides both active and passive geolocation infrastructure, enabling a variety of indoor guidance services and applications for end users. Its offerings include preparation and navigation assistance, opportunity tracking, safety services, and marketing data analysis for professionals, enhancing customer experience in sectors such as retail, leisure, travel, and healthcare. The company's innovative 3D-integrated platform utilizes indoor positioning technologies and user behavior analysis, allowing clients to navigate locations like exhibitions efficiently. A team of skilled engineers and technicians supports Planet Intus, focusing on Geographic Information Systems, mobile app development, and big data analytics to deliver superior operational insights and profitability for businesses.

Piavita

Seed Round in 2016
Piavita AG, founded in 2016 and headquartered in Zurich, Switzerland, specializes in developing advanced technology for the veterinary industry. The company has created a compact, matchbox-sized wearable device that accurately measures vital medical data from pets, including horses, without the need for clipping fur or extensive preparation. This innovative system is complemented by a web-based application that enables real-time monitoring and historical tracking of vital signs, improving the diagnostic capabilities available to veterinarians. By providing reliable insights into pet health and facilitating better communication between pet owners and veterinary professionals, Piavita aims to lead the digital transformation of veterinary care, addressing the gaps in current veterinary practices and enhancing the overall wellbeing of animals.

Qumram

Seed Round in 2016
Qumram provides a big data platform that enables compliant cross-channel recording of digital activities across web, social media, mobile apps, cloud, and on-premise environments. Its platform facilitates e-discovery, user experience intelligence, fraud detection, customer service enhancement, and regulatory compliance (e.g., MIFID-II, FFSA, FIDLEG, SEC, FINRA, DOL) for global financial institutions.

DomoHealth

Seed Round in 2016
DomoHealth is a company that specializes in smart home care services aimed at enhancing the quality of life for seniors and their families. Founded in 2011 by Edouard Goupy and Guillaume DuPasquier, the company emerged from personal experiences that highlighted the need for better care solutions. Between 2012 and 2014, DomoHealth conducted extensive trials and feasibility studies across various European countries, receiving validations from care networks, hospitals, and families. Since 2015, the company has marketed its services through a partner network in Europe, emphasizing a collaborative approach that involves listening to the needs of seniors, families, doctors, and nurses. DomoHealth has demonstrated the effectiveness of its services through partnerships with care networks and has been recognized as an expert in homecare within the framework of the European Commission's AAL program.

TestingTime

Angel Round in 2015
TestingTime AG is a Swiss company founded in 2014 and based in Zurich, specializing in online test user recruitment for usability studies, focus groups, interviews, and surveys. The company serves the UX and market research sectors by providing access to a diverse pool of over 350,000 test users, facilitating the selection of participants tailored to specific research needs. TestingTime employs online campaigns and referral strategies to acquire test users, while utilizing a smart rating system and predictive machine learning algorithms to ensure high-quality participants with a low no-show rate. Its services are offered in multiple languages, including German, French, Italian, Romansh, and English. TestingTime's platform enables large corporations, such as UBS, Zalando, Microsoft, and Accenture, to conduct qualitative and quantitative user research efficiently, enhancing their ability to gather valuable insights.

iMusician

Venture Round in 2015
iMusician Digital AG is a Swiss-based online platform founded in 2007, dedicated to empowering musicians in managing, selling, and monetizing their music. Located in Zurich, the company offers a comprehensive suite of tools that enables artists to distribute their music across major streaming services and sales platforms. iMusician focuses on simplifying the process for musicians by providing real-time sales tracking and copyright management, allowing them to concentrate on their creative work. With a small, passionate international team, iMusician Digital strives to support artists in navigating the complexities of the music industry and maximizing their revenue potential.

ActLight

Series A in 2015
ActLight SA, based in Lausanne, Switzerland, is a technology company specializing in the development of advanced photodetectors and photovoltaic energy harvesting solutions. Founded in 2010, ActLight has pioneered Dynamic PhotoDiode (DPD) technology, significantly enhancing the efficiency and accuracy of light sensing applications across various sectors, including mobile devices, healthcare, autonomous driving, and robotics. The company's innovations enable functionalities such as heart rate monitoring, gesture control, and 3D imaging. ActLight operates primarily on a licensing business model, generating revenue through licensing and royalty fees, as well as non-recurring engineering projects. As a fabless entity, it focuses on intellectual property in CMOS photonics and collaborates with leading institutions like EPFL to maintain its competitive edge. ActLight's expertise encompasses device design, materials integration, and circuit design, supported by a strong advisory board of industrial and scientific experts.

Medyria

Series A in 2015
Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.

Bluetector

Series A in 2015
Bluetector AG is a Swiss company specializing in the manufacture of wastewater treatment machinery, particularly focusing on the treatment of manure and biogas digestate. Established in 2012 and based in Root, Switzerland, Bluetector produces innovative wastewater treatment containers and systems. The company's technology provides a cost-effective solution for farms struggling with excess manure by converting it into clean water, thus eliminating the need for costly transport over long distances. By utilizing a containerized filtering system based on biological purification methods, Bluetector offers a sustainable approach to managing liquid waste, allowing environmental companies to clean and reuse wastewater in an environmentally friendly manner. Additionally, the company is involved in constructing and renovating municipal wastewater treatment plants, further contributing to effective wastewater management solutions.

Tecuro

Angel Round in 2014
Tecuro is a Switzerland-based medical technology company headquartered in Gerliswil, Luzern, focused on preventing urinary tract infections. It has developed an antimicrobial, skin-friendly platform delivered via external application, with the U-med Pad as a near-market-ready product to prevent urinary tract diseases, especially in women's urology. The platform enables non-systemic protection against UTIs and uro-vaginal infections and aims to counter antibiotic resistance through topical use. The technology is protected by patents, offering a long-term competitive edge and potential for additional products built on the same platform. Tecuro has completed the steps needed for series-compatible production, positioning itself to scale its external-application approach to reducing recurrent UTIs for women.

Lunchgate

Angel Round in 2014
Lunchgate AG, established in 2009 and based in Zurich, Switzerland, operates an online platform that facilitates restaurant discovery and table reservations. The platform offers users daily lunch menus, restaurant specialties, and 360-degree interior views, enabling them to explore and book tables at various dining establishments in the Zurich area.

iMusician

Series A in 2014
iMusician Digital AG is a Swiss-based online platform founded in 2007, dedicated to empowering musicians in managing, selling, and monetizing their music. Located in Zurich, the company offers a comprehensive suite of tools that enables artists to distribute their music across major streaming services and sales platforms. iMusician focuses on simplifying the process for musicians by providing real-time sales tracking and copyright management, allowing them to concentrate on their creative work. With a small, passionate international team, iMusician Digital strives to support artists in navigating the complexities of the music industry and maximizing their revenue potential.

CleanGreens Solutions SA

Seed Round in 2014
CleanGreens Solutions SA is an agricultural technology company based in Molondin, Switzerland, focused on innovative methods for growing fresh lettuce. Established in 2012, the company utilizes mobile aeroponics, which significantly reduces water consumption and minimizes contamination risks. By integrating advancements in logistics, agronomy, climate control, and automation, CleanGreens Solutions aims to achieve up to 70 times the productivity compared to traditional farming methods. This approach not only enhances the quality and longevity of the lettuce but also ensures that customers receive fresh and pesticide-free produce. Through its commitment to sustainability and efficiency, CleanGreens Solutions is transforming the supply chain for fresh greens.

Naviswiss

Series A in 2013
Naviswiss AG is a Swiss company focused on the development and commercialization of miniaturized surgical measuring, tracking, and navigation systems. Established in 2007 and based in Brugg, it specializes in creating innovative handheld devices that assist orthopedic surgeons in the precise implantation of artificial joints during procedures such as hip and knee replacements. Among its key products are CLIPON, a 3D measurement and navigation system, and LOCAS, a handheld device designed for surgical measurement and navigation. Additionally, NAVITAGS serve as markers to accurately determine the position of surgical instruments in space. These advanced systems provide immediate three-dimensional positional data, enhancing workflows for surgeons by facilitating cup alignment, leg length, and offset calculation while also reducing the time and costs associated with surgical operations.

arviem

Seed Round in 2013
arviem provides global cargo monitoring and supply chain visibility services, offering fully managed in-transit tracking and security monitoring across land, sea, and air. The company combines sensing, analytics, and operations support with advisory services such as business consulting and system integration to help clients optimize supply chains. Its platform delivers real-time data on shipment location and condition, enabling data-driven decisions related to logistics, risk management, and working capital. Serving industries including consumer products, consumer electronics, pharma and biochemical, chemical, logistics, and insurance, arviem operates across Europe, Asia, and the Americas. It offers 24/7 global monitoring through a managed service model and provides independent data to support trust and transparency. Strategic partnerships in technology and logistics enhance capabilities in tracking, security, and compliance. Headquartered in Rotkreuz, Switzerland, arviem supports importers, exporters, and logistics providers seeking end-to-end visibility of cargo movements.

Dahu

Series A in 2013
DAHU Sports is a Swiss company that manufactures ski boots for skiing, walking, hiking, and driving. Founded in 2011 by Nicolas Frey, DAHU Sports was officially launched in November 2013 with thousand pairs sold during the 1st season.

iMusician

Series A in 2013
iMusician Digital AG is a Swiss-based online platform founded in 2007, dedicated to empowering musicians in managing, selling, and monetizing their music. Located in Zurich, the company offers a comprehensive suite of tools that enables artists to distribute their music across major streaming services and sales platforms. iMusician focuses on simplifying the process for musicians by providing real-time sales tracking and copyright management, allowing them to concentrate on their creative work. With a small, passionate international team, iMusician Digital strives to support artists in navigating the complexities of the music industry and maximizing their revenue potential.

DomoHealth

Angel Round in 2012
DomoHealth is a company that specializes in smart home care services aimed at enhancing the quality of life for seniors and their families. Founded in 2011 by Edouard Goupy and Guillaume DuPasquier, the company emerged from personal experiences that highlighted the need for better care solutions. Between 2012 and 2014, DomoHealth conducted extensive trials and feasibility studies across various European countries, receiving validations from care networks, hospitals, and families. Since 2015, the company has marketed its services through a partner network in Europe, emphasizing a collaborative approach that involves listening to the needs of seniors, families, doctors, and nurses. DomoHealth has demonstrated the effectiveness of its services through partnerships with care networks and has been recognized as an expert in homecare within the framework of the European Commission's AAL program.

Agile Wind Power

Angel Round in 2012
Founded in 2010, Agile Wind Power specializes in developing innovative technology solutions for wind energy production. The company designs vertically rotating wind turbines that aim to reduce maintenance costs and enhance profitability and efficiency.

Uepaa®

Series A in 2012
Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

Shadow Government

Angel Round in 2011
Shadow Government is a company that focuses on creating innovative social gaming experiences by gamifying real countries, systems, and global events. Founded in 2011, it operates from offices in New York City and Zurich. The company's platform offers mobile games that blend elements of reality, governance, and entertainment, allowing players to engage in strategic country planning and decision-making. By blurring the lines between traditional gaming and real-world scenarios, Shadow Government aims to provide a unique interactive experience that fosters awareness and understanding of global dynamics.

Qvanteq

Seed Round in 2010
Founded in 2009, Qvanteq is a Swiss medtech company specializing in the development of innovative bioactive stents. Its flagship product, Qstent, addresses and mitigates clinical adverse effects of coronary and endovascular stents by controlling in-growth and reducing restenosis risk.

Locatee

Locatee AG is a Zurich-based company that specializes in workplace analytics solutions aimed at optimizing office space utilization. Founded in 2014, Locatee provides an innovative analytics platform that measures office occupancy without the need for hardware, allowing for both temporary and permanent assessments of space usage. By processing data from various sources through its patented technology, Locatee transforms complex information into clear insights, enabling corporate leaders and managers to make informed decisions about their real estate. The platform visualizes occupancy data effectively, helping organizations identify opportunities for optimization, realize cost savings, and improve the overall workplace experience across their portfolios.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.